Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C. (Q42983367)

From Wikidata
Jump to navigation Jump to search
scientific article published on 9 August 2012
edit
Language Label Description Also known as
English
Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C.
scientific article published on 9 August 2012

    Statements

    Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C. (English)
    Takashi Fujisawa
    Yukimasa Yamashita
    Shigeya Hirohata
    Kazunari Kitagaki
    Takatoshi Nakashima
    Yoshitake Hayashi
    Kobe Hepatitis Therapeutic Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit